Cigna Group $CI Stock Holdings Lifted by TD Asset Management Inc

TD Asset Management Inc increased its position in shares of Cigna Group (NYSE:CI) by 4.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 249,966 shares of the health services provider’s stock after acquiring an additional 11,471 shares during the quarter. TD Asset Management Inc owned 0.09% of Cigna Group worth $68,911,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Wilkerson Advisory Group LLC purchased a new position in Cigna Group during the 4th quarter worth approximately $25,000. Cedar Mountain Advisors LLC lifted its holdings in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. Kemnay Advisory Services Inc. purchased a new stake in shares of Cigna Group in the fourth quarter valued at $29,000. Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group in the fourth quarter worth $29,000. Finally, Creative Financial Designs Inc. ADV boosted its position in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after buying an additional 81 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their target price for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Wolfe Research reissued an “outperform” rating and issued a $315.00 price target on shares of Cigna Group in a research report on Tuesday, June 16th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Royal Bank Of Canada boosted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $339.45.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

CI opened at $282.24 on Friday. The stock has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a PEG ratio of 0.96 and a beta of 0.29. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a fifty day moving average price of $286.02 and a 200 day moving average price of $281.28.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the company posted $7.20 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.